Klow Blend is an 80 mg co-formulation containing GHK-Cu 50 mg, BPC-157 10 mg, TB-500 fragment 10 mg, and KPV 10 mg. It combines four chemically distinct research peptides rather than forming a new single molecular entity.
The components support multi-pathway experiments involving copper-peptide signaling, extracellular-matrix responses, cell migration, cytoskeletal organization, angiogenic signaling, and inflammatory-pathway models. The TB-500 component is the N-acetylated heptapeptide Ac-LKKTETQ—not full-length thymosin beta-4—and KPV is the Lys-Pro-Val tripeptide.
Because the complete blend has not been characterized as extensively as its individual components, studies should include suitable vehicle, blend, and component-level controls. Identity and purity should be assessed against batch-specific analytical documentation.
Research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, cosmetic, food, drug, or consumption purposes.